Clear Street’s Bausch Health BHC Stock Holding History

Clear Street’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,700,000	Closed	-$102M	–	455
2021 Q4	$102M	Buy	+3,700,000	New	+$99M	2.81%	8

Other funds holding BHC

Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Nomura Holdings

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Guardian Capital (Canada) Toronto, Ontario, Canada $3.78B AUM 33.04% 1-Year Est. Return

Clear Street's BHC Position: Q1 2022 in Review

Clear Street sold out of Bausch Health (BHC) in Q1 2022, closing a stake of 3,700,000 shares — an estimated $102M sold.

Clear Street first reported a position in BHC in Q4 2021 and held it in 1 quarter. The position peaked at $102M in Q4 2021. 370 funds tracked by Wall St. Rank hold BHC as of Q1 2022.

Clear Street reported no remaining Bausch Health position as of Q1 2022 after selling out during the quarter.
Clear Street sold 3,700,000 Bausch Health shares in Q1 2022, an estimated $102M.
Clear Street first reported a position in Bausch Health in Q4 2021 and held it in 1 quarter.
Clear Street's Bausch Health position peaked at $102M in Q4 2021.
370 funds tracked by Wall St. Rank held Bausch Health as of Q1 2022.

Based on Clear Street's 13F filing for Q1 2022, filed 11 May 2022.